Benign Hematology and Red Cell Disorder

During last decades research in some fields of hematology have been flourishing with an impressive increase in the amount of new drugs coming to clinical trials and on the market, thus changing patients' perspectives on the chance to be cured and greatly impacting patients' quality of life.



Research focused especially on some specific problems of some diseases, e.g. new drugs for reducing transfusion burden in beta-thalassemia or reducing the rate of vaso-occlusive crises in sickle cell disease, while other aspects of the same diseases or some other rare conditions (e.g. Blackfan Diamond Anemia, Erythrocytosis) remained only marginally addressed. For these latter, studies generally explored molecular and biology, but clinical studies (both observational and interventional) are largely missing.



The scope of this Research Topic on Benign Hematology and Red Cell Disorders is to stimulate research on less explored aspects of well studied disease, and on less studied and more rare disorders, with a perspective on the clinical course of the diseases, on potentially modifying factors and potential suggestions for therapeutic approaches. Original articles and Review articles will be welcomed for this scope.